Indian national Osman Syed, also known as Syed Osman, is being sought by authorities in the United States over allegations connected to a healthcare billing operation that prosecutors say generated more than US$79 million in fraudulent claims involving Medicare and Texas Medicaid. The allegations relate to diagnostic testing that investigators say was improperly billed through a Texas-based laboratory.
According to court documents cited by US authorities, Syed allegedly played a central role in a scheme involving BioDX Labs LLC. Prosecutors claim the company submitted claims for respiratory pathogen panel examinations that either were never carried out or were not medically warranted, raising concerns about the integrity of healthcare billing and the use of public funds.
Investigators further allege that personal details belonging to a doctor were used without that physician’s knowledge or approval when the claims were submitted. Authorities say the doctor had no previous connection with the patients concerned, had not treated them for respiratory illnesses and did not rely on the tests as part of their medical care.
Prosecutors also allege that steps were taken to make the claimed testing arrangements appear legitimate. According to the allegations, Syed falsely represented that BioDX Labs relied on outside reference laboratories to carry out the examinations, a claim investigators say was part of an effort to conceal the alleged billing activity.
The investigation has also examined the movement of money allegedly generated through the operation. US authorities say Syed and other alleged participants moved proceeds through international financial channels, including accounts connected with China, Hong Kong, Turkey, Greece and Switzerland. The allegations form part of the wider case being pursued by American law enforcement agencies.
Syed, 36, is believed by US authorities to have left the country in January 2024. Investigators say he crossed a land border before later travelling from Vancouver International Airport. Authorities have identified several possible locations where he may be found, including Canada, Cairo in Egypt and Hyderabad in India.
The charges reportedly facing Syed include healthcare fraud, conspiracy involving financial transactions connected to allegedly unlawful proceeds and conducting monetary transactions involving property derived from specified unlawful activity. Being wanted or charged does not establish guilt, and the allegations remain matters for the US judicial process.
The case comes amid continued US efforts to investigate large-scale healthcare fraud involving Medicare and other government-funded programs. In June 2026, the US Department of Justice announced charges against hundreds of defendants in a nationwide healthcare fraud enforcement operation involving billions of dollars in alleged false claims.
The allegations against Syed are separate from other Medicare fraud cases involving Indian nationals and should not be conflated with them. For example, US authorities previously prosecuted Mohammed Asif in a different case involving a diagnostic laboratory and Medicare claims for tests that prosecutors said had not been ordered or performed.
The current case remains focused on allegations surrounding BioDX Labs, the claimed respiratory testing, the use of a physician’s identifying information and the alleged movement of proceeds across international accounts. US authorities continue to list Syed as wanted, with India among the locations identified as a possible place where he could be located.
